Aim: Cardiospermum halicacabum L. is a climbing plant under Sapindaceae family. The plant leaf is used by traditional healers for treatment of various illnesses. Considering the ethno-medicinal value of C. halicacabum, the present study was taken up to evaluate single-dose acute toxicity study and repeated dose 28-day oral toxicity study (subacute) in Wistar albino rats.
INTRODUCTION
Cardiospermum halicacabum, known as "Balloon vine" or "Love in a puff," is a climbing plant under Sapindaceae family, widely distributed in tropical and subtropical Africa and Asia. It is an annual or sometimes perennial climber, commonly found as a weed in farmland. It is mentioned as one among the "Ten Sacred Flowers" of Kerala State in India, collectively known as "Dasapushpam." 1 Cardiospermum halicacabum is one of the ethnomedicinal plants of Western Ghats region of India. The plant is used by the local healers for treatment of various illnesses like joint pain, liver disorders, obesity management. [2] [3] [4] [5] Even though the plant has been reported for some biological activities, the details of safety and toxicity of the plant had not been reported so far. The present study has been taken up to evaluate safety dose of hydroalcoholic extract of C. halicacabum leaf through carrying out the single-dose acute toxicity and repeated dose 28-day oral toxi city study (subacute) in rodents as per OECD guidelines.
MATERIALS AND METHODS

Plant Collection and Extraction
The plant C. halicacabum was collected from the Western Ghats region (Palghat and Thrissur) of Kerala, India. Single-dose acute toxicity study was carried out as per OECD guidelines 423. The test drug (hydroalcoholic extract of C. halicacabum) was administered (2,000 mg/ kg bwt) through oral administration to three female rats once as step 1. After an observation period of 14 days, the test was repeated in another three animals as step 2.
Observation
The animals were observed individually after dosing, at least once during the first 30 minutes periodically during the first 24 hours, with special attention given during the first 4 hours, and daily thereafter for a total of 14 days. The animals were observed for morbidity, mortality, and clinical signs of toxicity (changes in skin and fur, eyes and mucous membrane, behavior pattern, tremors, convulsions, salivation, diarrhea, lethargy, sleep, and coma) for a period of 14 days. Body weight and feed consumption were recorded weekly.
Repeated Dose 28-day Oral Toxicity Study 6 Repeated dose 28-day oral toxicity study (subacute toxicity study) was carried out as per OECD guidelines 407. A total of 48 Wistar albino rats (12 weeks old) were randomized and equally divided into four groups (6 males and 6 females). Based on the findings of the acute study, the subacute study was carried out at three different doses. The animals in control group received distilled water. The animals of other three groups received the test compound dissolved in distilled water at the dose of 250, 500, and 1000 mg/kg bwt, for 28 days. Biochemical and hematological investigations had been carried out at the end of the study. [7] [8] [9] [10] This was followed by euthanization and organ necropsy as well as histopathological examination of various organs that included heart, lung, liver, spleen, stomach, kidney, testis/ ovary, sciatic nerve, brain and pancreas.
The animals were observed individually after dosing at least once during the first 30 minutes periodically during the first 24 hours, with special attention given during the first 4 hours, and daily thereafter for a total of 28 days. The animals were observed for morbidity, mortality, and clinical signs of toxicity (changes in skin and fur, eyes and mucous membrane, behavior pattern, tremors, convulsions, salivation, diarrhea, lethargy, sleep, and coma) for a period of 28 days. Body weight and feed consumption were recorded weekly.
Statistical Analysis
The data were expressed as mean ± standard error of mean (SEM). Statistical significance was analyzed using one-way analysis of variance with posttest.
RESULTS AND DISCUSSION
Single-dose Acute Toxicity Study
The acute study with single exposure of test extract at 2,000 mg/kg bwt showed that there were no preterminal deaths, no clinical signs of toxicity, and no abnormal behavior in the animals. Feed intake of the animals and weekly body weight gain were found to be adequate. The % body weight gain and % feed consumption in experimental animals for a period of 14 days in experimental steps 1 and 2 are recorded in Graphs 1 to 4.
Repeated Dose 28-day Oral Toxicity Study
There were no preterminal deaths, no toxic signs, and no abnormal behavior in the animals exposed to the test Values are expressed as mean ± SEM, N = 12 per group, p > 0.05, not significant compound in various dose levels, viz., low dose (250 mg/ kg bwt), average dose (500 mg/kg bwt), and high dose (1,000 mg/kg bwt). No clinical signs of toxicity were observed in any of the animals. The % body weight gain and % feed consumption in experimental animals for a period of 28 days had been recorded (Tables 1 and 2 ). It showed that feed intake of the animals and weekly body weight gain were found to be adequate.
JDRAS
The hematological parameters, such as white blood count (WBC) count, lymphocyte count, granulocyte count, monocyte count, red blood cell (RBC) count, and hemoglobin showed that there were no significant differences between control and experimental groups (Tables 3 to 6 ). Serum biochemical investigations including glucose, cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), liver function parameters, such as serum glutamic oxaloacetic transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), bilirubin, and renal function test parameters, such as creatinine and urea were carried out. The metabolic biochemical parameters showed that there were no significant differences between control and experimental groups (Tables 6 to 10 ). The urine analysis also evidenced that there were no abnormalities in the experimental group. The postmortem analysis showed that there was no significant difference in organ weight with respect to body weight among control and test groups (Tables 11 and 12 ). Values are expressed as mean ± SEM, N = 12 per group, p > 0.05, not significant 
Histopathology
No major histopathological changes were observed in any of the organs from the rats that received high dose of the extract compared with that of control. The histology study evidenced that the test extract was found to be safe at the prescribed dosages (Figs 1 to 6 ).
CONCLUSION
Single-dose acute oral toxicity study and repeated dose 28-day oral toxicity study exhibited the safety of the hydroalcoholic extract of C. halicacabum L. leaf at the selected doses, i.e., up to 1,000 mg/kg bwt, as there was no mortality and morbidity in test group animals. The detailed biochemical, hematological investigations, and histopathology studies also evidenced for the safety of the test drug. Further studies, such as biological activity, efficacy, or biopotency studies can be carried out using these safety dose details.
